Recent News

• 01.29.2025 - Vincerx Pharma, Inc. and Oqory, Inc. Highlight Promising Data for Oqory’s TROP2 Antibody Drug Conjugate, OQY-3258
• 01.23.2025 - Vincerx Pharma, Inc. Announces Reverse Stock Split
• 12.27.2024 - Vincerx Pharma Enters into a Binding Term Sheet for a Strategic Merger with Oqory, Inc.

Recent Filings

• 02.06.2025 - DEFA14A Additional definitive proxy soliciting materials and Rule 14(a)(12) material
• 02.06.2025 - 8-K Current report
• 01.24.2025 - S-3 Registration statement under Securities Act of 1933
• 01.23.2025 - EX-99.1 EX-99.1
• 01.21.2025 - 424B5 Prospectus [Rule 424(b)(5)]
• 01.06.2025 - 3 Initial statement of beneficial ownership of securities